Ritedose is growing in laboratory and drug development capacity - with the announcement of a $17M in-house cGMP laboratory, expected to open in early 2026. · GlobeNewswire Inc. COLUMBIA, S.C., Sept.
Enhances gene and cell therapy lab services across Europe and North America WILMINGTON, N.C.--(BUSINESS WIRE)--Pharmaceutical Product Development, LLC (PPD) is adding gene and cell therapy analytical ...
Alphora's new pilot plant in Mississauga, Ontario. Credit: Alphora Ontario-based process development firm Alphora will spend $2.5 million to add a third kilo lab operating under current Good ...
Ritedose is growing in laboratory and drug development capacity - with the announcement of a $17M in-house cGMP laboratory, expected to open in early 2026. Expanded microbiology lab and analytical ...
Expanded microbiology lab and analytical chemistry capabilities position Ritedose for accelerated growth. $17+ million investment fuels innovation and scale in drug development. COLUMBIA, S.C., Sept.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results